| 结局 指标 | ALP日 剂量(μg) | 文献数量(篇) | MD(95%CI) | 效应 模型 | 组内异 质性(I2) | 组间异 质性(I2) |
| HAMA | 400 | 5 [19] [20] [21] [23] [25] | −5.57 (−9.30, −2.21) | RE | 97% | 98% |
| 1200 | 2 [10] [16] | −9.36 (−11.80, −6.93) | 91% | |||
| HAMD | 400 | 3 [21] [23] [25] | −5.98 (−11.32, −0.64) | RE | 95% | 96% |
| 1200 | 3 [10] [16] [19] | −6.74 (−9.79, −3.69) | 97% |